Minaga, Kosuke https://orcid.org/0000-0001-5407-7925
Yoshikawa, Tomoe https://orcid.org/0000-0001-5275-2667
Yamashita, Yukitaka https://orcid.org/0000-0002-6347-2756
Akamatsu, Hiroko https://orcid.org/0000-0003-3042-2979
Ikenouchi, Maiko https://orcid.org/0000-0001-5816-5789
Ishii, Tatsuya https://orcid.org/0000-0003-2136-4703
Matsumoto, Hisakazu https://orcid.org/0000-0003-1772-8447
Iwagami, Hiroyoshi https://orcid.org/0000-0002-6312-8541
Nakatani, Yasuki https://orcid.org/0000-0001-7273-1986
Hatamaru, Keiichi https://orcid.org/0000-0001-9061-4361
Takenaka, Mamoru https://orcid.org/0000-0001-7308-4311
Akamatsu, Takuji https://orcid.org/0000-0002-6826-9829
Uenoyama, Yoshito https://orcid.org/0000-0003-4967-0059
Watanabe, Tomohiro https://orcid.org/0000-0001-7781-6305
Ono, Kazuo https://orcid.org/0000-0003-0914-7351
Chiba, Yasutaka
Kudo, Masatoshi https://orcid.org/0000-0002-4102-3474
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparison of the Diagnostic Performance of Newly Designed 21-Gauge and Standard 22-Gauge Aspiration Needles in Patients with Solid Pancreatic Masses
https://doi.org/10.1007/s10620-019-05624-4
Article History
Received: 12 November 2018
Accepted: 9 April 2019
First Online: 22 April 2019
Compliance with ethical standards
:
: Minaga K., Yoshikawa T., Yamashita Y., Akamatsu H., Ikenouchi M., Ishii T., Matsumoto H., Iwagami H., Nakatani Y., Hatamaru K., Takenaka M., Akamatsu T., Uenoyama Y., Watanabe T., Ono K., and Chiba Y. have no conflict of interest or financial ties to disclose. Kudo M. discloses grants from Chugai Pharmaceutical, Otsuka Pharmaceutical, Takeda Pharmaceutical, Taiho Pharma, Sumitomo Dainippon Pharma, Daiichi Sankyo Pharma, MSD, AbbVie INC., Medico’s Hirata INC., Astellas Pharma, and Bristol-Myers Squibb and advisory consulting for Kowa Pharmaceutical, MSD, Bayer Pharma, Ono Pharmaceutical, and Eisai Pharma.